ArticleFrontiers in pharmacology2024

Multicenter retrospective cohort study demonstrates superior safety profile of indobufen over aspirin for Post-CABG antiplatelet therapy.

Yu Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.